-
A complete enumeration and classification of two-locus disease models.
Hum Hered. 2000 Nov-Dec;50(6):334-49
PMID: 10899752
-
Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis.
Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):253-9
PMID: 7606200
-
Estrogen and the risk of breast cancer.
N Engl J Med. 2001 Jan 25;344(4):276-85
PMID: 11172156
-
A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation.
Genome Res. 2001 Mar;11(3):458-70
PMID: 11230170
-
Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.
Am J Obstet Gynecol. 1978 Feb 15;130(4):448-55
PMID: 629289
-
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones.
Br J Cancer. 1987 Nov;56(5):661-6
PMID: 3426933
-
Breast cancer epidemiology.
Cancer Res. 1988 Oct 15;48(20):5615-23
PMID: 3048646
-
Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7293-7
PMID: 3174634
-
Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk.
Cancer. 1989 Mar 1;63(5):948-57
PMID: 2914301
-
Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.
J Biochem. 1991 Sep;110(3):407-11
PMID: 1722803
-
Breast cancer (1)
N Engl J Med. 1992 Jul 30;327(5):319-28
PMID: 1620171
-
The risk of determining risk with multivariable models.
Ann Intern Med. 1993 Feb 1;118(3):201-10
PMID: 8417638
-
Reproductive factors and breast cancer.
Epidemiol Rev. 1993;15(1):36-47
PMID: 8405211
-
Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer.
Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):511-4
PMID: 8000303
-
Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk.
Cancer Res. 1995 Aug 15;55(16):3483-5
PMID: 7627950
-
Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989.
Am J Epidemiol. 1996 May 15;143(10):985-95
PMID: 8629617
-
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status.
J Natl Cancer Inst. 1996 Jun 5;88(11):756-8
PMID: 8637031
-
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
Lancet. 1996 Jun 22;347(9017):1713-27
PMID: 8656904
-
Molecular mechanisms of estrogen carcinogenesis.
Annu Rev Pharmacol Toxicol. 1996;36:203-32
PMID: 8725388
-
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.
Pharmacogenetics. 1996 Jun;6(3):243-50
PMID: 8807664
-
A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility.
Cancer Res. 1996 Nov 1;56(21):4965-9
PMID: 8895751
-
Who's afraid of epistasis?
Nat Genet. 1996 Dec;14(4):371-3
PMID: 8944011
-
A simulation study of the number of events per variable in logistic regression analysis.
J Clin Epidemiol. 1996 Dec;49(12):1373-9
PMID: 8970487
-
In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility.
Biochem Biophys Res Commun. 1997 Feb 3;231(1):227-30
PMID: 9070254
-
Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland.
Pharmacogenetics. 1997 Feb;7(1):65-71
PMID: 9110364
-
Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937-42
PMID: 9380738
-
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Cancer Res. 1997 Dec 15;57(24):5493-7
PMID: 9407957
-
Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.
Cancer Res. 1998 Jan 1;58(1):65-70
PMID: 9426059
-
Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.
Am J Hum Genet. 1998 Mar;62(3):573-84
PMID: 9497261
-
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
Cancer Res. 1998 May 15;58(10):2107-10
PMID: 9605753
-
Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Cancer Res. 1998 Nov 15;58(22):5038-41
PMID: 9823305
-
Catechol-O-methyltransferase and breast cancer risk.
Carcinogenesis. 1998 Nov;19(11):1943-7
PMID: 9855007
-
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet. 1997 Oct 11;350(9084):1047-59
PMID: 10213546
-
Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Cancer Res. 2000 Jul 1;60(13):3440-4
PMID: 10910054